Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Liabilities (2016 - 2025)

Conmed's Total Liabilities history spans 16 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Total Liabilities fell 3.79% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 3.79%, while the annual FY2025 figure was $1.3 billion, 3.79% down from the prior year.
  • Total Liabilities reached $1.3 billion in Q4 2025 per CNMD's latest filing, down from $1.3 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.6 billion in Q3 2022 to a low of $980.6 million in Q4 2021.
  • Average Total Liabilities over 5 years is $1.3 billion, with a median of $1.4 billion recorded in 2024.
  • Peak YoY movement for Total Liabilities: surged 58.28% in 2022, then fell 9.59% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $980.6 million in 2021, then soared by 58.28% to $1.6 billion in 2022, then dropped by 5.56% to $1.5 billion in 2023, then fell by 8.34% to $1.3 billion in 2024, then fell by 3.79% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Total Liabilities are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).